--- title: "Articore Group Limited (ASX:ATG) Held Back By Insufficient Growth Even After Shares Climb 28%" type: "News" locale: "en" url: "https://longbridge.com/en/news/273435302.md" description: "Articore Group Limited (ASX:ATG) shares rose 28% recently, but its price-to-sales (P/S) ratio remains low at 0.2x, indicating potential undervaluation. Despite a 21% increase over the past year, the company has struggled with declining revenue, posting an 11% drop last year and a 24% decline over three years. Analysts predict a further revenue decrease of 3.2% annually, contrasting with the industry’s expected growth of 6%. This weak outlook justifies the low P/S ratio, making significant share price increases unlikely in the near future." datetime: "2026-01-22T23:04:18.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273435302.md) - [en](https://longbridge.com/en/news/273435302.md) - [zh-HK](https://longbridge.com/zh-HK/news/273435302.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273435302.md) | [繁體中文](https://longbridge.com/zh-HK/news/273435302.md) # Articore Group Limited (ASX:ATG) Held Back By Insufficient Growth Even After Shares Climb 28% **Articore Group Limited** (ASX:ATG) shares have had a really impressive month, gaining 28% after a shaky period beforehand. Looking further back, the 21% rise over the last twelve months isn't too bad notwithstanding the strength over the last 30 days. In spite of the firm bounce in price, Articore Group's price-to-sales (or "P/S") ratio of 0.2x might still make it look like a buy right now compared to the Multiline Retail industry in Australia, where around half of the companies have P/S ratios above 0.8x and even P/S above 3x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the reduced P/S. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Check out our latest analysis for Articore Group ASX:ATG Price to Sales Ratio vs Industry January 22nd 2026 ### What Does Articore Group's P/S Mean For Shareholders? Articore Group hasn't been tracking well recently as its declining revenue compares poorly to other companies, which have seen some growth in their revenues on average. It seems that many are expecting the poor revenue performance to persist, which has repressed the P/S ratio. So while you could say the stock is cheap, investors will be looking for improvement before they see it as good value. If you'd like to see what analysts are forecasting going forward, you should check out our **free** report on Articore Group. ## What Are Revenue Growth Metrics Telling Us About The Low P/S? There's an inherent assumption that a company should underperform the industry for P/S ratios like Articore Group's to be considered reasonable. Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 11%. The last three years don't look nice either as the company has shrunk revenue by 24% in aggregate. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time. Turning to the outlook, the next three years should bring diminished returns, with revenue decreasing 3.2% per annum as estimated by the dual analysts watching the company. That's not great when the rest of the industry is expected to grow by 6.0% each year. In light of this, it's understandable that Articore Group's P/S would sit below the majority of other companies. Nonetheless, there's no guarantee the P/S has reached a floor yet with revenue going in reverse. There's potential for the P/S to fall to even lower levels if the company doesn't improve its top-line growth. ## The Key Takeaway Articore Group's stock price has surged recently, but its but its P/S still remains modest. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company. It's clear to see that Articore Group maintains its low P/S on the weakness of its forecast for sliding revenue, as expected. As other companies in the industry are forecasting revenue growth, Articore Group's poor outlook justifies its low P/S ratio. It's hard to see the share price rising strongly in the near future under these circumstances. It's always necessary to consider the ever-present spectre of investment risk. We've identified **1 warning sign with Articore Group**, and understanding should be part of your investment process. If you're **unsure about the strength of Articore Group's business**, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed. ### Related Stocks - [AtriCure, Inc. (ATRC.US)](https://longbridge.com/en/quote/ATRC.US.md) ## Related News & Research - [Barfresh Food Group Announces Board Director Resignation](https://longbridge.com/en/news/279053029.md) - [Does Insider Selling Versus Analyst Upgrades Reframe the Value Story at BGC Group (BGC)?](https://longbridge.com/en/news/278698710.md) - [Everest Group, Ltd. $EG Shares Sold by First Trust Advisors LP](https://longbridge.com/en/news/278352674.md) - [Alta Equipment Group Charts Cautious Recovery Path](https://longbridge.com/en/news/278465036.md) - [President and COO Of Affiliated Managers Group Sold $2.29M In Stock](https://longbridge.com/en/news/278578139.md)